Skip to main content
. 2014 Mar 30;2014(3):CD005195. doi: 10.1002/14651858.CD005195.pub3

Allen 2008

Methods Matched, nested case‐control study
Countries: Denmark, Germany, Greece, Italy, the Netherlands, Spain, Sweden, the UK
Participants Participants: approximately 130,000 men Inclusion criteria: male participants of the EPIC study
Name of parent cohort: European Prospective Investigation into Cancer and Nutrition (EPIC)
Recruitment: 1992 to 2000 Outcome assessment: at each country's study closure date (between June 1999 and January 2003)
Number of cases: Prostate cancer: 959 (male/female: 959/0) 
Case definition: incidence
Years of follow‐up: median 2.6 years (Greece) to 9.2 years (Sweden)
Type of selenium marker: plasma
Interventions d.n.a.
Outcomes Statistical methods: conditional logistic regression Variables controlled in analysis: BMI, smoking, alcohol consumption, physical activity, marital status, education
Variables controlled by matching: age, study centre, time of day of blood collection, time between blood collection and last meal, sex
Risk estimates [95% CI] Reference category: lowest quintile
Results: Prostate cancer highest quintile: OR 0.96 (95% CI 0.70 to 1.31)
Selenium levels in exposure categories lowest quintile < 62.0 µg/l
highest quintile ≥ 84.1 µg/l
Notes